- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- Changing Concepts in the Management of Asthma
Open Collections
UBC Faculty Research and Publications
Changing Concepts in the Management of Asthma Therapeutics Initiative (University of British Columbia)
Description
Therapeutics Letter 12 focusses on the optimal management of asthma in the primary care setting. Conclusions: regular inhaled corticosteroids are the main therapy in asthmatic patients with frequent symptoms or exacerbations. Use inhaled b2-agonists for intermittent relief or breakthrough symptoms only. For all treatments always have an objective goal and measure of efficacy and titrate the dose to identify the lowest dose that will achieve that goal.
Item Metadata
Title |
Changing Concepts in the Management of Asthma
|
Alternate Title |
Therapeutics Letter 12
|
Creator | |
Date Issued |
1996-02
|
Description |
Therapeutics Letter 12 focusses on the optimal management of asthma in the primary care setting. Conclusions: regular inhaled corticosteroids are the main therapy in asthmatic patients with frequent symptoms or exacerbations. Use inhaled b2-agonists for intermittent relief or breakthrough symptoms only. For all treatments always have an objective goal and measure of efficacy and titrate the dose to identify the lowest dose that will achieve that goal.
|
Subject | |
Genre | |
Type | |
Language |
eng
|
Notes |
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
|
Date Available |
2023-06-20
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0433591
|
URI | |
Affiliation | |
Peer Review Status |
Reviewed
|
Scholarly Level |
Faculty; Researcher
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International